SEC Form 4/A · accession 0001209191-17-027003
PORTOLA PHARMACEUTICALS INC · PTLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
William Lis
Officer — Chief Executive Officer · Director
Period of report
Apr 11, 2017
Accepted (ET)
Apr 14, 2017 · 6:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 11, 2017 | S | 6,750 | $36.06 | D | 4,730 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This amendment is being filed for the purpose of providing a correction to footnote 1 of the original, which is now restated as footnote 2 to this filing.
- F2The sale reported on this Form 4 was effected for the purpose of tax withholding in connection with the vesting of Restricted Stock Units and was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2017 and amended on March 21, 2017.